✦ LIBER ✦

Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study

✍ Scribed by A.-M. Aas; J. Öhrvik; K. Malmberg; L. Rydén; K. I. Birkeland; the DIGAMI 2 Investigators

Book ID: 109044734
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 11
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2008.00964.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alogliptin added to insulin therapy in p

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia

✍ J. Rosenstock; M. S. Rendell; J. L. Gross; P. R. Fleck; C. A. Wilson; Q. Mekki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Exenatide compared with long-acting insu

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

✍ M. J. Davies; R. Donnelly; A. H. Barnett; S. Jones; C. Nicolay; A. Kilcoyne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB

Lower within-subject variability of fast

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

✍ T. Haak; A. Tiengo; E. Draeger; M. Suntum; W. Waldhäusl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Association study of polymorphisms in In

Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

✍ Arun K. Tiwari; Clement C. Zai; Herbert Y. Meltzer; Jeffrey A. Lieberman; Daniel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## Objective Atypical antipsychotic drugs, in particular clozapine and olanzapine, influence cellular lipogenesis and are associated with metabolic side effects including weight gain. Insulin induced gene 2 (INSIG2) mediates feedback control of lipid synthesis and polymorphisms in the

Lipoprotein-associated phospholipase A2a

Lipoprotein-associated phospholipase A2and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

✍ T. L. Nelson; A. Kamineni; B. Psaty; M. Cushman; N. S. Jenny; J. Hokanson; C. Fu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 102 KB

Insulin detemir improves glycaemic contr

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study

✍ L. F. Meneghini; K. H. Rosenberg; C. Koenen; M. J. Merilainen; H.-J. Lüddeke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB